Danielle J. Brown
24 January 2024
Meanwhile, the Maryland Health Care for All Coalition is urging lawmakers to expand the authority of the board to reduce costs for all Marylanders, not just state employees, in the upcoming 2024 Legislative Session.
The health care advocacy group supports Senate Bill 388 and House Bill 340. Those bills would allow the board to determine whether it is in the state’s interest to set up a process to use upper payment limits on all purchases of prescription drugs, with the goal of reducing prescription drug costs for all Marylanders, not just those on state health plans.
Read the full article at marylandmatters.org.Last modified: January 30, 2024